A versatile RNA vector for delivery of coding and noncoding RNAs

Journal of Virology

Volumn 88, Issue 4, 2014, Pages 2333-2336

  Schmid, Sonja ^a   Zony, Lum C ^a   tenOever, Benjamin R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; BLOTTING, NORTHERN; DOGS; GENETIC ENGINEERING; GENETIC VECTORS; MADIN DARBY CANINE KIDNEY CELLS; RNA INTERFERENCE; RNA VIRUSES; TRANSDUCTION, GENETIC;

EID: 84893438707     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03267-13     Document Type: Article

References (33)

1. Sayed D, Abdellatif M. 2011. MicroRNAs in development and disease. Physiol. Rev. 91:827-887. http://dx.doi.org/10.1152/physrev.00006.2010.
2. Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297. http://dx.doi.org/10.1016/S0092-8674(04)00045-5.
3. Zeng Y, Wagner EJ, Cullen BR. 2002. Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol. Cell 9:1327-1333. http://dx.doi.org/10.1016/S1097-2765(02)00541-5.
4. Zeng Y, Cullen BR. 2003. Sequence requirements for micro RNA processing and function in human cells. RNA 9:112-123. http://dx.doi.org/10.1261/rna.2780503.
5. Fellmann C, Zuber J, McJunkin K, Chang K, Malone CD, Dickins RA, Xu Q, Hengartner MO, Elledge SJ, Hannon GJ, Lowe SW. 2011. Functional identification of optimized RNAi triggers using a massively parallel sensor assay. Mol. Cell 41:733-746. http://dx.doi.org/10.1016/j.molcel.2011.02.008.
6. Musacchio T, Torchilin VP. 2013. siRNA delivery: from basics to therapeutic applications. Front. Biosci. (Landmark Ed) 18:58-79. http://dx.doi.org/10.2741/4087.
7. tenOever BR. 2013. RNA viruses and the host microRNA machinery. Nat. Rev. Microbiol. 11:169-180. http://dx.doi.org/10.1038/nrmicro2971.
8. Perez JT, Varble A, Sachidanandam R, Zlatev I, Manoharan M, Garcia-Sastre A, ten Oever BR. 2010. Influenza A virus-generated small RNAs regulate the switch from transcription to replication. Proc. Natl. Acad. Sci. U.S.A. 107:11525-11530. http://dx.doi.org/10.1073/pnas.1001984107.
9. Parameswaran P, Sklan E, Wilkins C, Burgon T, Samuel MA, Lu R, Ansel KM, Heissmeyer V, Einav S, Jackson W, Doukas T, Paranjape S, Polacek C, dos Santos FB, Jalili R, Babrzadeh F, Gharizadeh B, Grimm D, Kay M, Koike S, Sarnow P, Ronaghi M, Ding SW, Harris E, Chow M, Diamond MS, Kirkegaard K, Glenn JS, Fire AZ. 2010. Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems. PLoS Pathog. 6:e1000764. http://dx.doi.org/10.1371/journal.ppat.1000764.
10. Langlois RA, Shapiro JS, Pham AM, ten Oever BR. 2012. In vivo delivery of cytoplasmic RNA virus-derived miRNAs. Mol. Ther. 20:367-375.
11. Rouha H, Thurner C, Mandl CW. 2010. Functional microRNA generated from a cytoplasmic RNA virus. Nucleic Acids Res. 38:8328-8337. http://dx.doi.org/10.1093/nar/gkq681.
12. Shapiro JS, Varble A, Pham AM, Tenoever BR. 2010. Noncanonical cytoplasmic processing of viral microRNAs. RNA 16:2068-2074. http://dx.doi.org/10.1261/rna.2303610.
13. Varble A, Chua MA, Perez JT, Manicassamy B, Garcia-Sastre A, ten Oever BR. 2010. Engineered RNA viral synthesis of microRNAs. Proc. Natl. Acad. Sci. U.S.A. 107:11519-11524. http://dx.doi.org/10.1073/pnas.1003115107.
14. Chua MA, Schmid S, Perez JT, Langlois RA, Tenoever BR. 2013. Influenza A virus utilizes suboptimal splicing to coordinate the timing of infection. Cell Rep. 3:23-29. http://dx.doi.org/10.1016/j.celrep.2012.12.010.
15. Marsh GA, Hatami R, Palese P. 2007. Specific residues of the influenza A virus hemagglutinin viral RNA are important for efficient packaging into budding virions. J. Virol. 81:9727-9736. http://dx.doi.org/10.1128/JVI.01144-07.
16. Martínez-Sobrido L, Cadagan R, Steel J, Basler CF, Palese P, Moran TM, García-Sastre A. 2010. Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of influenza virus neutralizing antibodies. J. Virol. 84:2157-2163.
17. Gao Q, Chou YY, Doganay S, Vafabakhsh R, Ha T, Palese P. 2012. The influenza A virus PB2, PA, NP, andMsegments play a pivotal role during genome packaging. J. Virol. 86:7043-7051. http://dx.doi.org/10.1128/JVI.00662-12.
18. Perez JT, Pham AM, Lorini MH, Chua MA, Steel J, ten Oever BR. 2009. MicroRNA-mediated species-specific attenuation of influenza A virus. Nat. Biotechnol. 27:572-576. http://dx.doi.org/10.1038/nbt.1542.
19. Anokye-Danso F, Trivedi CM, Juhr D, Gupta M, Cui Z, Tian Y, Zhang Y, Yang W, Gruber PJ, Epstein JA, Morrisey EE. 2011. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 8:376-388. http://dx.doi.org/10.1016/j.stem.2011.03.001.
20. Makeyev EV, Zhang J, Carrasco MA, Maniatis T. 2007. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol. Cell 27:435-448. http://dx.doi.org/10.1016/j.molcel.2007.07.015.
21. Kelly EJ, Hadac EM, Cullen BR, Russell SJ. 2010. MicroRNA antagonism of the picornaviral life cycle: alternative mechanisms of interference. PLoS Pathog. 6:e1000820. http://dx.doi.org/10.1371/journal.ppat.1000820.
22. Kelly EJ, Hadac EM, Greiner S, Russell SJ. 2008. Engineering microRNA responsiveness to decrease virus pathogenicity. Nat. Med. 14:1278-1283. http://dx.doi.org/10.1038/nm.1776.
23. Kelly EJ, Nace R, Barber GN, Russell SJ. 2010. Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting. J. Virol. 84: 1550-1562. http://dx.doi.org/10.1128/JVI.01788-09.
24. Langlois RA, Varble A, Chua MA, Garcia-Sastre A, ten Oever BR. 2012. Hematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses. Proc. Natl. Acad. Sci. U.S.A. 109:12117-12122. http://dx.doi.org/10.1073/pnas.1206039109.
25. Pham AM, Langlois RA, TenOever BR. 2012. Replication in cells of hematopoietic origin is necessary for Dengue virus dissemination. PLoS Pathog. 8:e1002465. http://dx.doi.org/10.1371/journal.ppat.1002465.
26. Barnes D, Kunitomi M, Vignuzzi M, Saksela K, Andino R. 2008. Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines. Cell Host Microbe 4:239-248. http://dx.doi.org/10.1016/j.chom.2008.08.003.
27. Edge RE, Falls TJ, Brown CW, Lichty BD, Atkins H, Bell JC. 2008. A let-7 MicroRNA-sensitive vesicular stomatitis virus demonstrates tumorspecific replication. Mol. Ther. 16:1437-1443. http://dx.doi.org/10.1038/mt.2008.130.
28. Varble A, Benitez AA, Schmid S, Sachs D, Shim JV, Rodriguez-Barrueco R, Panis M, Crumiller M, Silva JM, Sachidanandam R, Tenoever BR. 2013. An in vivo RNAi screening approach to identify host determinants of virus replication. Cell Host Microbe 14:346-356. http://dx.doi.org/10.1016/j.chom.2013.08.007.
29. Gu S, Jin L, Zhang Y, Huang Y, Zhang F, Valdmanis PN, Kay MA. 2012. The loop position of shRNAs and pre-miRNAs is critical for the accuracy of dicer processing in vivo. Cell 151:900-911. http://dx.doi.org/10.1016/j.cell.2012.09.042.
30. Varble A, tenOever BR. 2011. Implications of RNA virus-produced miRNAs. RNA Biol. 8:190-194. http://dx.doi.org/10.4161/rna.8.2.13983.
31. Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, Davis CR, Marion P, Salazar F, Kay MA. 2006. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441:537-541. http://dx.doi.org/10.1038/nature04791.
32. Grimm D, Wang L, Lee JS, Schurmann N, Gu S, Borner K, Storm TA, Kay MA. 2010. Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver. J. Clin. Invest. 120:3106-3119. http://dx.doi.org/10.1172/JCI43565.
33. Monto AS, Ohmit SE, Petrie JG, Johnson E, Truscon R, Teich E, Rotthoff J, Boulton M, Victor JC. 2009. Comparative efficacy of inactivated and live attenuated influenza vaccines. N. Engl. J. Med. 361:1260-1267. http://dx.doi.org/10.1056/NEJMoa0808652.